UTIs

"RECCE 327 Phase I/II Trial"

Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Staff Reporter March 14, 2024 0

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced...

India’s reputation as the “Pharmacy to the World” is Potentially Under Threat Substandard Imports of IPA add to the Quality Burden

Staff Reporter September 25, 2024 0

Dr. Vivek Kumar, Senior Consulting Cosmetic & Plastic Surgeon at Sculpt Clinics, Delhi, India, smiling.

Sculpt Clinics Introduces New Laser Hair Removal Technology

Staff Reporter September 6, 2024 0

HEAL Foundation Announces Healthcare CSR Summit & Awards in New Delhi

Staff Reporter August 22, 2024 0

Apsara Ice Creams Muskaan Initiative 53rd Anniversary Celebration

Apsara Ice Creams to launch Muskaan initiative on its 53rd anniversary

Staff Reporter August 16, 2024 0

Milann Fertility Center launches 'Milann's Embrace' initiative during World Breastfeeding Week 2024.

Milann Fertility Center Celebrates World Breastfeeding Week with ‘Milann’s Embrace’ Initiative

Staff Reporter August 9, 2024 0